Industry: Healthcare
Format: PPT*, PDF, EXCEL
Delivery Timelines: Contact Sales
Report Type: Ongoing
Report ID: PMRREP34670
The market for cartilage repair is estimated to reach a valuation of US$2.4 Bn by the year 2031, at a CAGR of 7.1%, during the forecast period 2024 to 2031.
Key Highlights of the Market
|
Market Attributes |
Key Insights |
|
Cartilage Repair Market Size (2024) |
US$1.5 Bn |
|
Market Size (2031) |
US$2.4 Bn |
|
Forecast Growth Rate (CAGR 2024 to 2031) |
7.1% |
|
Historical Growth Rate (CAGR 2019 to 2023) |
6.3% |
Advancements in cartilage regeneration technology, as well as the rising prevalence of bone and joint disorders, including osteoarthritis (OA) and arthritis, are expected to drive growth in the global market.
The escalating impact of obesity and other related factors, as well as the expanding geriatric population, can be attributed to the increasing prevalence of OA. In the US, approximately 34.2 billion individuals, or 10.5% of the population, have diabetes, according to the Centers for Disease Control and Prevention (CDC).
Additionally, the market is experiencing growth as a result of the adoption of smart devices and technological advancements, including artificial intelligence (AI) and data analytics.
The worldwide rise in the prevalence of diabetes and obesity is anticipated to stimulate the expansion of the global cartilage repair industry.
The demand for cartilage restoration products is expected to increase due to the increasing prevalence of obesity, particularly in Latin America, and the MEA region, and the association between diabetes and increased cartilage loss.
It is anticipated that this demographic, which is susceptible to chronic diseases, will be instrumental in stimulating market growth and increasing demand for cartilage repair procedures.
The global cartilage repair market has experienced notable growth from 2019 to 2023, driven by advancements in technology, increasing awareness about sustainability, and cost-efficiency consideration.
In 2019, the market began to gain traction as businesses and consumers started recognizing the benefits of cartilage repair and refurbishment over purchasing new cartilages.
The market was primarily driven by small and medium-sized enterprises (SMEs) looking to cut costs without compromising on print quality.
The growing awareness about environmental sustainability also played a crucial role, with many organizations opting for repaired cartilages to reduce their carbon footprint. This year marked the beginning of organized efforts to promote cartilage repair services, with several small-scale providers entering the market.
By 2023, the market had reached a level of maturity, characterized by widespread adoption and increased competition.
The market saw the entry of several new players, offering innovative repair solutions and competitive pricing. Existing players focused on enhancing their service offerings, such as providing comprehensive maintenance packages and extending warranties on repaired cartilages.
The continued emphasis on sustainability and cost-efficiency ensured steady demand for cartilage repair services. Market consolidation began to take place, with mergers and acquisitions aimed at expanding service capabilities and geographic reach.
Increasing Prevalence of Joint and Cartilage Disorders
Osteoarthritis is one of the most common joint disorders, characterized by the degeneration of cartilage. As the global population ages, the incidence of osteoarthritis continues to rise, creating a substantial demand for effective cartilage repair treatments.
The growing number of elderly individuals suffering from joint pain and reduced mobility underscores the need for advanced therapeutic solutions to restore joint function and improve quality of life.
The increase in participation in sports and physical activities has led to a higher incidence of cartilage injuries. Athletes and active individuals are prone to cartilage damage due to repetitive stress and traumatic injuries.
The demand for cartilage repair is particularly high among younger populations who seek to return to their active lifestyles post-injury. This trend is driving the market for innovative and effective cartilage repair techniques.
Advancements in Regenerative Medicine, and Tissue Engineering
Stem cell therapy has emerged as a promising approach in cartilage repair. The ability of stem cells to differentiate into cartilage cells and promote tissue regeneration has garnered significant attention.
Advances in stem cell research and the development of minimally invasive delivery methods are enhancing the efficacy and safety of these treatments. The potential for stem cell therapy to provide long-term solutions for cartilage repair is a major driver of market growth.
The development of biomaterials and scaffold-based therapies has revolutionized the field of cartilage repair. These materials provide a supportive environment for cell growth and tissue regeneration, improving the outcomes of repair procedures.
Innovations in biocompatible materials and 3D printing technologies are enabling the creation of custom-designed scaffolds that enhance the healing process. The continuous evolution of these technologies is fuelling cartilage repair market expansion.
Favorable Reimbursement Policies and Regulatory Approvals
The availability of favorable reimbursement policies for cartilage repair procedures is encouraging more patients to seek treatment. Insurance coverage for advanced repair techniques and regenerative therapies reduces the financial burden on patients, making these treatments more accessible. The support from healthcare payers is a crucial driver of market growth.
The approval of new and innovative cartilage repair therapies by regulatory bodies is facilitating their market entry and adoption.
Regulatory agencies are recognizing the potential of advanced regenerative treatments and providing pathways for their approval. The growing number of approved therapies is expanding the range of options available to patients and healthcare providers, driving market growth.
High Cost of Advanced Treatments
One of the primary restraints in the cartilage repair market is the high cost associated with advanced treatment options.
Procedures like autologous chondrocyte implantation (ACI), matrix-induced autologous chondrocyte implantation (MACI), and stem cell therapies involve complex processes and specialized equipment. These treatments require the extraction and cultivation of cells, the use of sophisticated biomaterials, and often multiple surgical interventions.
The overall expenses for such procedures, including pre-operative and post-operative care, can be prohibitive for many patients.
Although some regions have favorable reimbursement policies, the extent of coverage for advanced cartilage repair procedures is often limited. Many insurance providers categorize these treatments as elective or experimental, resulting in partial or no reimbursement.
Patients may have to bear substantial out-of-pocket costs, which can deter them from opting for these advanced solutions. This financial burden restricts access to effective treatments, especially for individuals without comprehensive insurance or those in low- and middle-income regions.
Conventional treatments for cartilage damage, such as physical therapy, pain management, and simpler surgical procedures, are generally more cost-effective compared to advanced cartilage repair techniques.
While these traditional methods may not provide long-term solutions, their lower costs and broader insurance coverage make them more accessible.
The economic challenge of justifying the high upfront costs of advanced cartilage repair, even with their superior outcomes, can slow down their adoption in favor of less expensive alternatives.
Development of Advanced Regenerative Therapies
Stem cell therapy is at the forefront of regenerative medicine. Future opportunities lie in the development of more effective stem cell-based treatments for cartilage repair.
Companies can invest in research to identify the most potent stem cell types, optimize delivery methods, and improve the differentiation of stem cells into cartilage cells.
Innovations in this area could lead to therapies that offer better integration with existing tissues and more durable repair outcomes.
Gene therapy offers the potential to modify cells at the genetic level to enhance cartilage repair. Industry participants can explore the development of gene editing technologies such as CRISPR-Cas9 to promote cartilage regeneration.
These therapies could be designed to stimulate the production of cartilage-specific proteins or inhibit inflammatory responses, providing a more targeted and effective approach to treatment.
Cell-based Cartilage Repair Accounts for 65% Market Share
|
Market Segment by Modalities |
Market Value Share 2023 |
|
Cell-based |
65% |
Based on modalities, the global cartilage repair market is further segmented into cell-based and non-cell-based modalities, where the cell-based segment dominates the market share. Cell-based and non-cell-based methodologies are the primary modalities that are investigated.
The increasing popularity of autologous chondrocyte transplants as a surgical treatment for damaged articular cartilage, including chondral and osteochondral lesions, is the reason for this growth. It is anticipated to serve as a substantial catalyst for market expansion and is expected to expand as a result of this growing preference.
The Hyaline segment dominates the market with 55% of the total market share.
|
Market Segment by Application |
Market Value Share 2023 |
|
Hyaline |
55% |
Based on the application, the global cartilage repair market is further classified into hyaline and fibrocartilage, where the hyaline segment dominates the market share, owing to the escalating prevalence of physical trauma on a global scale, which can lead to osteochondral and chondral lesions in patients.
The world is rapidly urbanizing, which is resulting in a rise in the number of individuals who are exposed to risk factors for trauma, including violence and traffic accidents.
Trauma is a substantial factor in the US’ mortality and disability rates, as per the National Center for Biotechnology Information (NCBI).
Trauma is responsible for approximately 79,000 fatalities annually among individuals under the age of 45, surpassing both infective disease-related deaths and non-communicable disease-related deaths. Trauma is the primary cause of prospective years of life loss for individuals under the age of 65.
The fibrocartilage segment is anticipated to experience a substantial CAGR during the forecast period, primarily as a result of the growing demand for minimally invasive cartilage repair procedures among patients. These procedures are linked to a reduced risk of complications and a shortened recovery time than conventional surgical procedures.
Nearly 45% of Global Market Revenue Concentrated in North American
|
Region |
Market Value Share 2023 |
|
North America |
45% |
North America was the largest cartilage repair market, with a share of over 45%. It is anticipated that this market will maintain its dominance throughout the forecast period.
The market expansion in the US, and Canada can be attributed to the burgeoning prevalence of musculoskeletal diseases, the presence of a target population, and changes in the behaviors of individuals.
Additionally, the market in Europe is anticipated to be significantly impacted by the increasing prevalence of osteoporosis in countries such as the United Kingdom, Germany, and France.
Fragility fractures, which are fractures that occur from a standing height of 10 feet or less due to osteoporosis, necessitate hospital treatment for approximately 500,000 individuals annually.
Throughout the forecast period, Asia Pacific is anticipated to experience the fastest CAGR of 5.8%. Hip and knee replacement and surgeries are among the most frequently conducted and effective procedures in this region.
It is anticipated that the Asia Pacific knee segment in the market will expand as a result of the increasing geriatric population and the prevalence of knee disorders. Market expansion is also influenced by factors such as the increasing likelihood of osteoporosis-related fractures and accidents.
Furthermore, market growth is further stimulated by the efforts of market participants to introduce advanced products in the region. The primary indication for these interventions is osteoarthritis, which frequently destroys articular cartilage and cartilage damage.
November 2023
Smith & Nephew PLC bought CartiHeal Ltd. CartiHeal Ltd. was a developer of Agili-C sports medicine. Smith & Nephew PLC is a top medical technology company for repair, regeneration, and replacement of soft and hard tissues.
July 2022
Bioventus Inc., a top company that makes innovations for active mending, bought CartiHeal. Bioventus will be able to offer better products to treat osteoarthritis and osteochondral defects in the knee thanks to this purchase.
The global cartilage repair market is competitive and dynamic, driven by innovations in regenerative medicine, biocompatible materials, and personalized treatment approaches.
Major players like Smith & Nephew, Zimmer Biomet, and Stryker lead the market with comprehensive product portfolios and strategic initiatives.
Emerging companies such as Vericel Corporation and Histogenics Corporation contribute to market growth through novel therapies and technological advancements.
As the demand for effective cartilage repair solutions continues to grow, competition and innovation are expected to intensify, driving further advancements in the field.
|
Attributes |
Details |
|
Forecast Period |
2024 - 2031 |
|
Historical Data Available for |
2019 - 2023 |
|
Market Analysis |
US$ Billion for Value |
|
Key Regions Covered |
|
|
Key Companies Profiled |
|
|
Pricing |
Available upon request |
By Modalities
By Application
By Region
To know more about delivery timeline for this report Contact Sales
The global cartilage repair market is estimated to exhibit a CAGR of 7.1% during the forecast period.
North America is the leading region in the market.
The global cartilage repair market is segmented based on modalities and application.
Zimmer Biomet, Stryker, Collagen Solutions (US) LLC, BD (Becton, Dickinson and Company), Arthrex, Inc., are some of the major key companies in the market.
The global cartilage repair market valuation is stated to be valued US$1.5 billion in 2024.
